Centrum Medyczne ENEL-MED S.A.
ENE.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 736 | PLN 619 | PLN 495 | PLN 441 |
| % Growth | 18.9% | 25% | 12.2% | – |
| Cost of Goods Sold | PLN 677 | PLN 593 | PLN 484 | PLN 419 |
| Gross Profit | PLN 59 | PLN 26 | PLN 11 | PLN 22 |
| % Margin | 8% | 4.2% | 2.2% | 5% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 13 | PLN 10 | PLN 10 | PLN 9 |
| SG&A Expenses | PLN 36 | PLN 34 | PLN 37 | PLN 24 |
| Sales & Mktg Exp. | PLN 22 | PLN 24 | PLN 27 | PLN 15 |
| Other Operating Expenses | -PLN 5 | -PLN 11 | -PLN 6 | -PLN 6 |
| Operating Expenses | PLN 31 | PLN 23 | PLN 31 | PLN 17 |
| Operating Income | PLN 28 | PLN 3 | -PLN 21 | PLN 5 |
| % Margin | 3.8% | 0.5% | -4.2% | 1.1% |
| Other Income/Exp. Net | -PLN 9 | PLN 5 | -PLN 7 | -PLN 5 |
| Pre-Tax Income | PLN 19 | PLN 10 | -PLN 28 | PLN 0 |
| Tax Expense | PLN 5 | PLN 2 | -PLN 4 | PLN 2 |
| Net Income | PLN 15 | PLN 8 | -PLN 24 | -PLN 1 |
| % Margin | 2% | 1.3% | -4.8% | -0.3% |
| EPS | 0.52 | 0.29 | -0.83 | -0.059 |
| % Growth | 79.3% | 134.9% | -1,316.4% | – |
| EPS Diluted | 0.52 | 0.29 | -0.83 | -0.059 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 24 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 1 | PLN 0 | PLN 2 | PLN 0 |
| Interest Expense | PLN 10 | PLN 10 | PLN 6 | PLN 6 |
| Depreciation & Amortization | PLN 75 | PLN 71 | PLN 62 | PLN 57 |
| EBITDA | PLN 105 | PLN 91 | PLN 40 | PLN 63 |
| % Margin | 14.3% | 14.7% | 8.1% | 14.4% |